查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1616728

微导管市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Microcatheters Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球微导管市场价值为 9.855 亿美元，预计 2024 年至 2032 年复合年增长率为 5.1%。 这种增长主要是由微创外科手术需求的增长和导管技术进步推动的。微创外科手术的激增是市场扩张的主要催化剂。这些手术因其相对于传统开放性手术的优势而受到关注，例如恢復时间更快、併发症风险更低、疼痛和疤痕更少以及住院时间更短。因此，神经病学、心臟病学、肿瘤学和周边血管治疗等不同医学领域明显转向微创手术 (MIS)。

该行业分为产品、设计、应用、最终用途和地区。该市场将产品细分为输送微导管、诊断微导管、抽吸微导管和可操纵微导管。值得注意的是，可操纵领域预计将成长最快，复合年增长率为 5.3%。这种激增归因于它们在心血管血管造影中的使用不断增加，与标准微导管相比，它们的成功率更高，手术时间更短。

其独特的功能允许即时角度调整，提高超选择性血管插管的效率。微导管的应用涵盖心血管、神经血管、週边血管、肿瘤学等。心血管领域在市场中占据主导地位，2023 年销售额约为 4.012 亿美元。世界卫生组织 (WHO) 强调了这个问题的严重性，指出 CVD 是全球头号死因，占所有死亡人数的 30% 以上。这一强劲数字是由神经血管和心血管疾病盛行率上升以及经皮冠状动脉介入手术的增加所推动的。此外，政府措施、成熟的医疗设施网路以及先进技术产品的现成也推动了这一成长。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 9.855 亿美元
预测值 16 亿美元
复合年增长率 5.1%

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 微创外科手术数量不断增加
      • 慢性病患者数量不断增加
      • 技术进步
    • 产业陷阱与挑战
      • 与微导管相关的高风险和复杂性
  • 成长潜力分析
  • 监管场景
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 报销场景
  • 差距分析
  • 2023 年定价分析
  • 价值链分析
  • 生态系测绘

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 输送微导管
  • 诊断微导管
  • 抽吸微导管
  • 可操纵微导管

第 6 章：市场估计与预测：按设计，2021 - 2032

  • 主要趋势
  • 单腔微导管
  • 双腔微导管

第 7 章：市场估计与预测：按应用分类，2021 - 2032

  • 主要趋势
  • 心血管
  • 神经血管
  • 周围血管
  • 肿瘤学
  • 其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 门诊手术中心

第 9 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • Acrostak
  • Asahi Intecc USA, Inc.
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc (Abbott Laboratories, Inc.)
  • Cook Medical
  • Embolx, Inc.
  • Integer Holdings Corporation
  • Medtronic plc
  • Merit Medical System, Inc.
  • Penumbra, Inc.
  • Reflow Medical, Inc.
  • Stryker Corporation
  • Teleflex Corporation
  • Terumo Corporation
  • Transit Scientific
简介目录
Product Code: 3572

The Global Microcatheters Market was valued at USD 985.5 million in 2023 and is projected to grow at a CAGR of 5.1% from 2024 to 2032. This growth is largely fueled by rising demand for minimally invasive surgical procedures and technological advancements in catheters. The surge in minimally invasive surgical procedures is a primary catalyst for the market expansion. These surgeries have gained traction due to their advantages over traditional open surgeries, such as quicker recovery times, reduced complication risks, less pain and scarring, and shorter hospital stays. Consequently, there has been a pronounced shift towards minimally invasive surgeries (MIS) across diverse medical fields, including neurology, cardiology, oncology, and peripheral vascular treatments.

The industry is divided into product, design, application, end-use, and region. The market segments products into delivery microcatheters, diagnostic microcatheters, aspiration microcatheters, and steerable microcatheters. Notably, the steerable segment is projected to grow the fastest, at a 5.3% CAGR. This surge is attributed to their rising use in cardiovascular angiography, where they offer enhanced success rates and shorter procedural times compared to standard microcatheters.

Their unique feature allows real-time angulation adjustments, boosting the efficiency of super-selective vessel cannulation. Applications of microcatheters span cardiovascular, neurovascular, peripheral vascular, oncology, and more. The cardiovascular segment dominated the market, raking in approximately USD 401.2 million in 2023. This prominence is largely due to the escalating global incidence of cardiovascular disorders (CVDs). The World Health Organization (WHO) highlights the gravity, noting CVDs as the top global death cause, accounting for over 30% of all deaths.In 2023, North America generated a substantial USD 331.4 million in microcatheter revenue. This robust figure is driven by a rising prevalence of neurovascular and cardiovascular diseases and an uptick in percutaneous coronary intervention procedures. Furthermore, bolstering this growth are government initiatives, a network of established healthcare facilities, and the ready availability of advanced technological products.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$985.5 Million
Forecast Value$1.6 Billion
CAGR5.1%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing number of minimally invasive surgical procedures
      • 3.2.1.2 Increasing number of patients suffering from chronic diseases
      • 3.2.1.3 Technological advancements
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High risk and complexity associated with microcatheters
  • 3.3 Growth potential analysis
  • 3.4 Regulatory scenario
  • 3.5 Technology landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Future market trends
  • 3.9 Reimbursement scenario
  • 3.10 Gap analysis
  • 3.11 Pricing analysis, 2023
  • 3.12 Value chain analysis
  • 3.13 Ecosystem mapping

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Delivery microcatheter
  • 5.3 Diagnostic microcatheter
  • 5.4 Aspiration microcatheter
  • 5.5 Steerable microcatheter

Chapter 6 Market Estimates and Forecast, By Design, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Single lumen microcatheter
  • 6.3 Dual lumen microcatheter

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cardiovascular
  • 7.3 Neurovascular
  • 7.4 Peripheral vascular
  • 7.5 Oncology
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Acrostak
  • 10.2 Asahi Intecc USA, Inc.
  • 10.3 Boston Scientific Corporation
  • 10.4 Cardiovascular Systems, Inc (Abbott Laboratories, Inc.)
  • 10.5 Cook Medical
  • 10.6 Embolx, Inc.
  • 10.7 Integer Holdings Corporation
  • 10.8 Medtronic plc
  • 10.9 Merit Medical System, Inc.
  • 10.10 Penumbra, Inc.
  • 10.11 Reflow Medical, Inc.
  • 10.12 Stryker Corporation
  • 10.13 Teleflex Corporation
  • 10.14 Terumo Corporation
  • 10.15 Transit Scientific